| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.69B | 36.23B | 38.30B | 35.46B | 36.67B | 35.36B |
| Gross Profit | 15.48B | 13.80B | 16.15B | 13.47B | 12.28B | 10.87B |
| EBITDA | 9.35B | 8.73B | 9.61B | 8.85B | 6.77B | 6.51B |
| Net Income | 4.06B | 4.74B | 4.46B | 4.34B | 4.04B | 3.64B |
Balance Sheet | ||||||
| Total Assets | 75.30B | 71.97B | 77.26B | 77.41B | 71.13B | 73.74B |
| Cash, Cash Equivalents and Short-Term Investments | 13.98B | 22.42B | 15.71B | 22.97B | 18.70B | 21.66B |
| Total Debt | 21.36B | 15.93B | 23.02B | 22.91B | 24.06B | 29.32B |
| Total Liabilities | 27.20B | 22.43B | 29.31B | 30.43B | 29.70B | 36.21B |
| Stockholders Equity | 47.96B | 49.38B | 47.76B | 46.74B | 41.26B | 37.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.55B | -10.73B | 6.98B | 4.42B | 2.65B |
| Operating Cash Flow | 0.00 | 20.85B | -8.45B | 10.00B | 6.29B | 3.66B |
| Investing Cash Flow | 0.00 | 676.00M | 4.09B | -9.02B | -3.94B | -700.00M |
| Financing Cash Flow | 0.00 | -10.81B | -2.94B | -712.00M | -5.40B | 5.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥98.63B | 14.21 | ― | 2.88% | -5.41% | 10.29% | |
70 Outperform | ¥17.48B | 16.51 | ― | 1.49% | 0.06% | 5.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥34.34B | 18.14 | ― | 2.59% | 0.68% | 33.74% | |
60 Neutral | ¥66.07B | 10.29 | ― | 2.18% | 6.54% | 140.15% | |
56 Neutral | ¥6.17B | 16.24 | ― | 2.29% | -0.18% | -65.47% | |
54 Neutral | ¥16.72B | 30.45 | ― | 1.13% | 3.36% | -15.06% |